Fed. Circ. Says Merck Patent Nixed By On-Sale Bar
The Federal Circuit ruled Friday that a Merck patent claim related to oral contraceptives Safyral and Beyaz is invalid because Merck had offered it for sale before filing a patent, reversing...To view the full article, register now.
Already a subscriber? Click here to view full article